Town Total Health, a specialty pharmacy and a portfolio company of BelHealth Investment Partners, has completed the acquisition of Special Design Health Care, a specialty pharmacy.
Special Design Health Care is an independent specialty pharmacy serving gastroenterologists and hepatologists and their patients in more than 20 states. The company was founded in 1989 and is based in Cape Girardeau, MO (www.specialdesignhealthcare.com).
Town Total, acquired by BelHealth in December 2012, is a specialty pharmacy servicing patients with various chronic diseases and complex medical conditions including: Hepatitis C, HIV, chronic inflammatory diseases, oncology and transplant maintenance therapy. The company provides a range of specialty services for patients, providers, payors and pharmaceutical companies including reimbursement assistance, patient education, clinical adherence programs and prompt delivery of critical medications. The company is based in Melville, NY (www.towntotal.com).
According to BelHealth, Town Total in combination with Special Design is at the forefront of the evolving Hepatitis C market and is well positioned as a full service specialty pharmacy servicing patients from New York to Colorado.
Joy Doll, R.N., formerly a Director at Special Design, has become Senior Vice President and leads Town Total’s Hepatitis C business unit. In addition to Ms. Doll, her sales and operational team will expand Town Total’s sales and clinical staff plus add a nursing capability to offer even greater patient support and improved outcomes.
“Special Design is the perfect addition to Town Total, expanding our geographic coverage and expanding our service offering more deeply into Hepatitis C and inflammatory conditions such as RA, Crohns and psoriasis. Additionally, we are thrilled to have Joy Doll join the team and lead our effort in what is becoming a highly dynamic Hepatitis C market,” said Michael Nameth, CEO of Town Total.
BelHealth Investment Partners is a healthcare private equity firm focused on lower middle market companies. The firm invests from $10 million to $25 million in companies in three healthcare segments: services, information technology, and products & distribution. BelHealth is based in New York (www.belhealth.com).
“Following the recent launch of two highly anticipated Hepatitis C drugs by Gilead and Janssen (Sovaldi and Olysio), we are pleased to increase our investment into the specialty pharmacy industry and expand Town Total’s Hepatitis C business and our national footprint. Special Design perfectly fits both of these objectives,” said Harold Blue, BelHealth’s Managing Partner.
© 2013 PEPD • Private Equity’s Leading News Magazine • 12-17-13
